vital pulp therapy with calcium-silicate cements: report of two cases

Authors

hengameh ashraf

afsaneh rahmati

neda amini

abstract

this article describes successful use of calcium-enriched mixture (cem) cement and biodentine in apexogenesis treatment in two 8-year-old patients, one with immature permanent molar diagnosed primarily with irreversible pulpitis and the other with partially vital maxillary central incisor. after access cavity preparation, partial pulpotomy in molar and full pulpotomy in central was performed, and the remaining pulps was capped with either biodentine or cem cement, in each tooth. the crowns were restored with composite filling material at the following visit. the post-operative radiographic and clinical examinations (approx. average of 16 months) showed that both treated teeth remained functional, with complete root development and apex formation. a calcified bridge was produced underneath the capping material. no further endodontic intervention was necessary. considering the healing potential of immature vital pulps, the use of cem cement and biodentine for apexogenesis might be an applicable choice. these new endodontic biomaterials might be appropriate for vital pulp therapies in an immature tooth. however, further clinical studies with longer follow-up periods are recommended.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Vital pulp therapy with two different calcium-silicate cements: two cases report

It is a worthy aim to preserve the pulp vitality in teeth with immature root in order to continue the root's maturation. Traumatic injuries and caries are two main reasons for pulp exposure in immature teeth. This article describes two vital pulp therapies on two patients, a nine-year-old boy with traumatized central tooth and a 10-year-old boy with caries exposure in a premolar tooth. Both tee...

full text

Vital Pulp Therapy with Calcium-Silicate Cements: Report of Two Cases

This article describes successful use of calcium-enriched mixture (CEM) cement and Biodentine in apexogenesis treatment in two 8-year-old patients, one with immature permanent molar diagnosed primarily with irreversible pulpitis and the other with partially vital maxillary central incisor. After access cavity preparation, partial pulpotomy in molar and full pulpotomy in central was performed, a...

full text

Nanostructure of calcium silicate hydrates in cements.

Calcium silicate hydrate (CSH) is the major volume phase in the matrix of Portland cement concrete. Total x-ray scattering measurements with synchrotron x rays on synthetic CSH(I) shows nanocrystalline ordering with a particle diameter of 3.5(5) nm, similar to a size-broadened 1.1 nm tobermorite crystal structure. The CSH component in hydrated tricalcium silicate is found to be similar to CSH(I...

full text

Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview - part I: vital pulp therapy.

Mineral trioxide aggregate (MTA) is a bioactive endodontic cement (BEC) mainly comprised of calcium and silicate elements. The cement was introduced by Torabinejad in the 1990s and has been approved by the Food and Drug Administration to be used in the United States in 1997. A number of new BECs have also been introduced to the market, including BioAggregate, Biodentine, BioRoot RCS, calcium-en...

full text

Vital pulp therapy in vital permanent teeth with cariously exposed pulp: a systematic review.

INTRODUCTION This systematic review aims to illustrate the outcome of vital pulp therapy, namely direct pulp capping, partial pulpotomy, and full pulpotomy, in vital permanent teeth with cariously exposed pulp. METHODS Electronic database MEDLINE via Ovid, PubMed, and Cochrane databases were searched. Hand searching was performed through reference lists of endodontic textbooks, endodontic-rel...

full text

My Resources

Save resource for easier access later


Journal title:
iranian endodontic journal

جلد ۱۲، شماره ۱، صفحات ۱۱۲-۱۱۵

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023